GNMT and neoplasm: A recent study identified a novel tumorigenic mechanism of dysregulation of phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein (PREX2) expression in a tumor environment where GNMT expression is inhibited.